June 3, 2020Celltrion’s COVID-19 Antiviral Shows Positive Results in Pre-Clinical StudiesThe company plans to begin human clinical trials next month.
June 3, 2020BerGenBio Doses First COVID-19 Patient with Bemcentinib in ACCORD TrialBemcentinib is the first candidate to be tested as a part of the UK’s ACCORD trial of multiple early-stage COVID-19 treatments.
June 3, 2020BerGenBio Doses First COVID-19 Patient With Bemcentinib in UK ACCORD InitiativeBerGenBio has announced that the first COVID-19 patient was dosed with bemcentinib in a phase 2 trial to evaluate the drug as a potential treatment.
